Activation of EGFR [48] has been shown to contribute to COPD-associated phenotypes such as mucus overproduction and secretion, which would explain why inhibition reduces the MUC5AC levels within the bronchospheres lumen despite CSE treatment. The gene discussed is EGFR; the disease is chronic obstructive pulmonary disease.